Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,580.47
(
-0.67%
)
US TECH 100
23,642.80
(
-0.64%
)
Dow Jones
45,835.17
(
-0.84%
)
Brent Oil
106.70
(
0.11%
)
Bitcoin
69,455.95
(
-2.51%
)
News Focus
News Focus
Post# of 257259
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122799
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Double_Bagel post# 209630

Sunday, 03/05/2017 7:06:22 PM

Sunday, March 05, 2017 7:06:22 PM

Post# of 257259
Re: MYL’s Copaxone ANDAs

Please see #msg-112812696, #msg-112817624, #msg-112848073, and #msg-112804827 for comments on this question. Also, bear in mind that the FDA has had MYL’s 20mg-Copaxone ANDA under review for 7.5 (!) years (#msg-41441618); if MYL truly understood how to replicate Copaxone, one would think they would have approval of the 20mg ANDA by now.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now